Free Articles, Free Web Content, Reprint Articles
Wednesday, May 30, 2012
 
Free Articles, Free Web Content, Reprint ArticlesRegisterAll CategoriesTop AuthorsSubmit Article (Article Submission)ContactSubscribe Free Articles, Free Web Content, Reprint Articles
ADVERTISEMENTS
 

Chances Of Getting Neuroendocrine Carcinoma

The colon is a major part of the large intestine, whereas a carcinoma is a malignant cancer that crops up from epithelial cells.

One of the most aggressive and disastrous forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that more often than not it is detected late into the advanced stages when it is extremely hard to curb it and treat it.

As the symptoms of neuroendocrine colon cancer become visible only at very advanced stages, the survival rate drops at an alarming rate. The tumors are always malignant, and mostly detected with distant metastases. Most recent surveys show that reports tell us that in almost all cases of neuroendocrine cancer ends in death.

Though chances of neuroendocrine carcinoma in colon are extremely unlikely, if one is affected the patient’s condition becomes much worse than patients who suffer from adenocarcinoma.

Research reveals that the end results of this cancer do not change with age, sex or tumor location. However, neuroendocrine colon carcinoma will depend heavily on the tumor’s stage. Standard cases have revealed that people in stage 1 and 2 of cancer will generally not experience  neuroendocrine colon cancer. But alternately in many cases when the tumor is in stage 3 or 4, it is a laborious and tough job to treat the neuroendocrine colon carcinoma.

Sadly, medical science has very few methods to treat this kind of cancer. A more common technique that doctors regularly use is immunohistochemical staining methods. This method helps the doctors to detect the seriousness of neuroendocrine colon cancer and really helps determine the most helpful medication and a way to treat it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. This involves staining of the tumor with the antibody A-80 which helps to identify the quantum of neuroendocrine differentiation and the extent of damage on the health of the patient.

Neuroendocrine colon carcinoma is hard to treat and in a case study in which a number of patients suffered from this particular disease were examined, it was observed that the overall survival rate for this disease was only about seven months. While in a predominant stageBusiness Management Articles, these rates drop to less than five months The great majority of these cases were at first found to be as carcinoids but they soon became in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery is not always a perfect or even viable treatment so surgery may not even provide a satisfactory cure. So this makes it important to detect this disease as soon as possible and prescribe the right medication.

Article Tags: Neuroendocrine Colon Cancer, Neuroendocrine Carcinoma, Neuroendocrine Colon, Colon Cancer, Colon Carcinoma

Source: Free Articles from ArticlesFactory.com

ABOUT THE AUTHOR


P Abbey owns and operates http://www.coloncarcinomatips.com Colon Hydro Therapie



Health
Business
Finance
Travel
Home Repair
Technology
Computers
Family
Communication
Entertainment
Autos
Marketing
Self Help
Sports
Home Business
Education
ECommerce
Law
Other
Internet
Partners


Page loaded in 0.041 seconds